The purines: potent and versatile small molecule inhibitors and modulators of key biological targets

Bioorganic & Medicinal Chemistry
Michel Legraverend, David S Grierson

Abstract

The goal of this review is to highlight the wide range of biological activities displayed by purines, with particular emphasis on new purine-based agents which find potential application as chemical-biology tools and/or therapeutic agents. The expanding interest in the biological properties of polyfunctionalized purine derivatives issues, in large part, from the development of rapid high-throughput screening essays for new protein targets, and the corresponding development of efficient synthetic methodology adapted to the construction of highly diverse purine libraries. Purine-based compounds have found new applications as inducers of interferon and lineage-committed cell dedifferentiation, agonists and antagonists of adenosine receptors, ligands of corticotropin-releasing hormone receptors, and as inhibitors of HSP90, Src kinase, p38alpha MAP kinase, sulfotransferases, phosphodiesterases, and Cdks. The scope of application of purines in biology is most certainly far from being exhausted. Testing purine derivatives against the multitude of biological targets for which small molecule probes have not yet been found should thus be a natural reflex.

Associated Clinical Trials

References

Feb 7, 1992·Journal of Medicinal Chemistry·K A JacobsonM Williams
Sep 1, 1994·European Journal of Biochemistry·J VeselýS Leclerc
Jul 29, 1998·Bioorganic & Medicinal Chemistry·S A Poulsen, R J Quinn
Oct 1, 1998·Structure·Z WangE J Goldsmith
Feb 17, 1999·Bioorganic & Medicinal Chemistry Letters·P ImbachJ Zimmermann
May 7, 1999·Bioorganic & Medicinal Chemistry Letters·J P BeckG L Trainor
May 14, 1999·Molecular Medicine Today·S A BaldwinJ D Young
Mar 14, 2000·Bioorganic & Medicinal Chemistry Letters·S E KeelingM J Sheehan
Jun 24, 2000·Bioorganic & Medicinal Chemistry Letters·A K BakkestuenJ M Nolsøe
Sep 30, 2000·Bioorganic & Medicinal Chemistry Letters·L D ArnoldS E Ratnofsky
Oct 12, 2000·Biochemical and Biophysical Research Communications·P WangM M Billah
Jan 3, 2001·Nature Structural Biology·K ParangP A Cole
Jan 10, 1997·The Journal of Organic Chemistry·David A. NugielJeffrey W. Corbett
Dec 14, 2001·Journal of Medicinal Chemistry·Y T ChangP G Schultz
Jan 5, 2002·Expert Opinion on Biological Therapy·Alison Maloney, Paul Workman
Mar 5, 2002·Microbiology and Molecular Biology Reviews : MMBR·Paul R Graves, Timothy A J Haystead
Mar 12, 2002·Journal of Combinatorial Chemistry·Sheng DingPeter G Schultz
Jun 1, 2002·Bioorganic & Medicinal Chemistry Letters·David J CalderwoodPaul Rafferty
Jun 1, 2002·Bioorganic & Medicinal Chemistry Letters·Andrew F BurchatBarbara S Skinner
Aug 17, 2002·Bioorganic & Medicinal Chemistry Letters·Ruth ArnoldMauro Zurini
Aug 23, 2002·Pharmacology & Therapeutics·Doriano FabbroPaul W Manley
Sep 5, 2002·Chembiochem : a European Journal of Chemical Biology·Young-Tae ChangSung Ho Ryu
Sep 19, 2002·Trends in Pharmacological Sciences·Marie KnockaertLaurent Meijer
Sep 24, 2002·Nature Structural Biology·Thomas G DaviesHayley J Whitfield
Oct 24, 2002·Bioorganic & Medicinal Chemistry Letters·Vladimír KrystofMiroslav Strnad
Nov 15, 2002·International Journal of Cancer. Journal International Du Cancer·Steven J McClueDavid P Lane

❮ Previous
Next ❯

Citations

Jun 17, 2011·ACS Combinatorial Science·Barbora VankováJan Hlavác
Apr 24, 2012·Journal of Medicinal Chemistry·Matthias D'hoogheNorbert De Kimpe
May 7, 2010·Physical Chemistry Chemical Physics : PCCP·Stanislav StandaraMichal Straka
Aug 5, 2011·Physical Chemistry Chemical Physics : PCCP·Stanislav StandaraRadek Marek
May 4, 2011·Proceedings of the National Academy of Sciences of the United States of America·Ning-Ai LiuShlomo Melmed
Dec 11, 2007·Nucleosides, Nucleotides & Nucleic Acids·Kathleen TooLivia Vivas
Jan 1, 2009·Acta Crystallographica. Section E, Structure Reports Online·Michal RouchalRobert Vícha
Jan 1, 2009·Acta Crystallographica. Section E, Structure Reports Online·Michal RouchalRobert Vícha
Jan 1, 2009·Acta Crystallographica. Section E, Structure Reports Online·Michal RouchalRobert Vícha
Jan 1, 2010·Acta Crystallographica. Section E, Structure Reports Online·Michal RouchalRobert Vícha
Jan 6, 2012·Acta Crystallographica. Section E, Structure Reports Online·Ana B CaballeroJuan M Salas
Sep 13, 2012·Acta Crystallographica. Section E, Structure Reports Online·Federico Andrés GiovagnoliRobert Vícha
Dec 17, 2008·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Rosanna SolinasPaul W Baures
Mar 1, 2014·Chemical Communications : Chem Comm·Anders Foller Larsen, Trond Ulven
Apr 1, 2014·European Journal of Medicinal Chemistry·Mariusz MojzychVladimír Kryštof
Aug 12, 2014·European Journal of Medicinal Chemistry·Felicia Phei Lin Lim, Anton V Dolzhenko
Jan 13, 2010·Cellular and Molecular Life Sciences : CMLS·Michael J Schell
Jun 22, 2011·Expert Opinion on Therapeutic Patents·Samir MessaoudiMouad Alami
Sep 25, 2014·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Sandrine HouzéLuc Demange
Feb 26, 2016·European Journal of Medicinal Chemistry·Sahil SharmaKunal Nepali
Sep 3, 2009·Annals of the New York Academy of Sciences·Józefa Wesierska-Gadek, Vladimír Krystof
Jul 7, 2015·Chemistry & Biology·Jeremiah J TrauschRobert T Batey
Apr 11, 2017·Chemical Communications : Chem Comm·Balaram MohapatraSandeep Verma
Apr 18, 2015·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Jeannette Calderón-ArancibiaCristian O Salas
Jan 25, 2017·Scientia pharmaceutica·Shabnam Farzaneh, Afshin Zarghi
Mar 10, 2018·Organic & Biomolecular Chemistry·Vladimir E OslovskySergey N Mikhailov
Jun 9, 2015·Chemical Communications : Chem Comm·Vijay GayakheAnant R Kapdi
Oct 10, 2018·Current Protocols in Nucleic Acid Chemistry·Vladimir E OslovskySergey N Mikhailov
Jun 5, 2013·Chemistry : a European Journal·Jens MaesBert U W Maes
Apr 4, 2008·Organic & Biomolecular Chemistry·Zahia MahioutRoland Barret
Feb 26, 2009·Natural Product Reports·Zhong Jin
Nov 11, 2009·Angewandte Chemie·François Besselièvre, Sandrine Piguel
Feb 3, 2007·Organic & Biomolecular Chemistry·Tuomas Karskela, Harri Lönnberg
Mar 8, 2014·Nature Reviews. Immunology·Andrew D Wells, Peter A Morawski
Dec 14, 2011·Organic & Biomolecular Chemistry·Viktor O IaroshenkoPeter Langer
Aug 16, 2014·Molecular BioSystems·Jacek WierzchowskiDavid Shugar
Mar 1, 2012·Magnetic Resonance in Chemistry : MRC·Eliška ProcházkováMartin Dračínský
Mar 24, 2016·Acta Crystallographica. Section E, Crystallographic Communications·Lígia R GomesFernanda Borges

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.